Original Research
Published on 19 May 2022
Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort
in Pharmacoepidemiology

- 2,559 views
- 2 citations
Original Research
Published on 19 May 2022
in Pharmacoepidemiology
Original Research
Published on 17 May 2022
in Pharmacoepidemiology
Original Research
Published on 16 May 2022
in Pharmacoepidemiology
Original Research
Published on 12 May 2022
in Pharmacoepidemiology
Original Research
Published on 10 May 2022
in Pharmacoepidemiology
Brief Research Report
Published on 04 May 2022
in Pharmacoepidemiology
Original Research
Published on 27 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 26 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 26 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 20 Apr 2022
in Pharmacoepidemiology
Systematic Review
Published on 20 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 20 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 20 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 14 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 08 Apr 2022
in Pharmacoepidemiology
Original Research
Published on 05 Apr 2022
in Pharmacoepidemiology